Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

[This corrects the article DOI: 10.1371/journal.pone.0054014.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-12, Vol.16 (12), p.e0261994-e0261994
Hauptverfasser: Shah, Manish A, Wainberg, Zev A, Catenacci, Daniel V T, Hochster, Howard S, Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C, Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0261994
container_issue 12
container_start_page e0261994
container_title PloS one
container_volume 16
creator Shah, Manish A
Wainberg, Zev A
Catenacci, Daniel V T
Hochster, Howard S
Ford, James
Kunz, Pamela
Lee, Fa-Chyi
Kallender, Howard
Cecchi, Fabiola
Rabe, Daniel C
Keer, Harold
Martin, Anne-Marie
Liu, Yuan
Gagnon, Robert
Bonate, Peter
Liu, Li
Gilmer, Tona
Bottaro, Donald P
description [This corrects the article DOI: 10.1371/journal.pone.0054014.].
doi_str_mv 10.1371/journal.pone.0261994
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2613264344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A687760106</galeid><doaj_id>oai_doaj_org_article_3a8c73388258421cbed41f983d337c90</doaj_id><sourcerecordid>A687760106</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4384-921d8a8e8e7bf065fb1fb861770f8211736a04eadb7ec7c6b0b8bf2c7838a8073</originalsourceid><addsrcrecordid>eNptUttuEzEUXCEQLYU_QGCJlyI1qW_xpQ9IVUjCilatSOHV8nq9iaPNOti7Rf0Vvhan2VYNqvzgo-OZOT6jybL3CA4R4eh05bvQ6Hq48Y0dQsyQlPRFdogkwQOGIXn5pD7I3sS4gnBEBGOvswNCJUWSycPs79iHYE3rfHMGrpc6WpDnYN525R2Y3Oq6061rFgCDrz5ui7lZ2rKrbQS-AldB12Dqg00YV4Dj2fw7IoxAIT-fAHM5uTn9NZlNf2CQN0tXuNaHE-AacJ00bdNG8Me1S3BpWx3b1DJgloqQ7rFujA1vs1eVrqN9199H2c_p5Gb8bXBxNcvH5xcDQ4mgA4lRKbSwwvKigmxUFagqBEOcw0pghDhhGlKry4Jbww0rYCGKChsuSKJBTo6yjzvdTe2j6m2NKjlKMKOE0oTId4jS65XaBLfW4U557dR9w4eF0iEtUFtFtDCcECHwSFCMTGFLiiopSEkINxImrS_9tK5Y29IkI5KLe6L7L41bqoW_VYJJKRFOAse9QPC_OxtbtXbR2LrWjfXd_b8pxpITlKCf_oM-v12PWui0gGsqn-aarag6Z4JzBhFkCTV8BpVOadfOpAxWLvX3CHRHMMHHGGz1uCOCapvgh8-obYJVn-BE-_DUn0fSQ2TJP_3_6vA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2613264344</pqid></control><display><type>article</type><title>Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Shah, Manish A ; Wainberg, Zev A ; Catenacci, Daniel V T ; Hochster, Howard S ; Ford, James ; Kunz, Pamela ; Lee, Fa-Chyi ; Kallender, Howard ; Cecchi, Fabiola ; Rabe, Daniel C ; Keer, Harold ; Martin, Anne-Marie ; Liu, Yuan ; Gagnon, Robert ; Bonate, Peter ; Liu, Li ; Gilmer, Tona ; Bottaro, Donald P</creator><creatorcontrib>Shah, Manish A ; Wainberg, Zev A ; Catenacci, Daniel V T ; Hochster, Howard S ; Ford, James ; Kunz, Pamela ; Lee, Fa-Chyi ; Kallender, Howard ; Cecchi, Fabiola ; Rabe, Daniel C ; Keer, Harold ; Martin, Anne-Marie ; Liu, Yuan ; Gagnon, Robert ; Bonate, Peter ; Liu, Li ; Gilmer, Tona ; Bottaro, Donald P</creatorcontrib><description>[This corrects the article DOI: 10.1371/journal.pone.0054014.].</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0261994</identifier><identifier>PMID: 34941969</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Cancer patients ; Care and treatment ; Metastasis ; Stomach cancer</subject><ispartof>PloS one, 2021-12, Vol.16 (12), p.e0261994-e0261994</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Shah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Shah et al 2021 Shah et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4384-921d8a8e8e7bf065fb1fb861770f8211736a04eadb7ec7c6b0b8bf2c7838a8073</citedby><cites>FETCH-LOGICAL-c4384-921d8a8e8e7bf065fb1fb861770f8211736a04eadb7ec7c6b0b8bf2c7838a8073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699912/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699912/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34941969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, Manish A</creatorcontrib><creatorcontrib>Wainberg, Zev A</creatorcontrib><creatorcontrib>Catenacci, Daniel V T</creatorcontrib><creatorcontrib>Hochster, Howard S</creatorcontrib><creatorcontrib>Ford, James</creatorcontrib><creatorcontrib>Kunz, Pamela</creatorcontrib><creatorcontrib>Lee, Fa-Chyi</creatorcontrib><creatorcontrib>Kallender, Howard</creatorcontrib><creatorcontrib>Cecchi, Fabiola</creatorcontrib><creatorcontrib>Rabe, Daniel C</creatorcontrib><creatorcontrib>Keer, Harold</creatorcontrib><creatorcontrib>Martin, Anne-Marie</creatorcontrib><creatorcontrib>Liu, Yuan</creatorcontrib><creatorcontrib>Gagnon, Robert</creatorcontrib><creatorcontrib>Bonate, Peter</creatorcontrib><creatorcontrib>Liu, Li</creatorcontrib><creatorcontrib>Gilmer, Tona</creatorcontrib><creatorcontrib>Bottaro, Donald P</creatorcontrib><title>Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>[This corrects the article DOI: 10.1371/journal.pone.0054014.].</description><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Metastasis</subject><subject>Stomach cancer</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptUttuEzEUXCEQLYU_QGCJlyI1qW_xpQ9IVUjCilatSOHV8nq9iaPNOti7Rf0Vvhan2VYNqvzgo-OZOT6jybL3CA4R4eh05bvQ6Hq48Y0dQsyQlPRFdogkwQOGIXn5pD7I3sS4gnBEBGOvswNCJUWSycPs79iHYE3rfHMGrpc6WpDnYN525R2Y3Oq6061rFgCDrz5ui7lZ2rKrbQS-AldB12Dqg00YV4Dj2fw7IoxAIT-fAHM5uTn9NZlNf2CQN0tXuNaHE-AacJ00bdNG8Me1S3BpWx3b1DJgloqQ7rFujA1vs1eVrqN9199H2c_p5Gb8bXBxNcvH5xcDQ4mgA4lRKbSwwvKigmxUFagqBEOcw0pghDhhGlKry4Jbww0rYCGKChsuSKJBTo6yjzvdTe2j6m2NKjlKMKOE0oTId4jS65XaBLfW4U557dR9w4eF0iEtUFtFtDCcECHwSFCMTGFLiiopSEkINxImrS_9tK5Y29IkI5KLe6L7L41bqoW_VYJJKRFOAse9QPC_OxtbtXbR2LrWjfXd_b8pxpITlKCf_oM-v12PWui0gGsqn-aarag6Z4JzBhFkCTV8BpVOadfOpAxWLvX3CHRHMMHHGGz1uCOCapvgh8-obYJVn-BE-_DUn0fSQ2TJP_3_6vA</recordid><startdate>20211223</startdate><enddate>20211223</enddate><creator>Shah, Manish A</creator><creator>Wainberg, Zev A</creator><creator>Catenacci, Daniel V T</creator><creator>Hochster, Howard S</creator><creator>Ford, James</creator><creator>Kunz, Pamela</creator><creator>Lee, Fa-Chyi</creator><creator>Kallender, Howard</creator><creator>Cecchi, Fabiola</creator><creator>Rabe, Daniel C</creator><creator>Keer, Harold</creator><creator>Martin, Anne-Marie</creator><creator>Liu, Yuan</creator><creator>Gagnon, Robert</creator><creator>Bonate, Peter</creator><creator>Liu, Li</creator><creator>Gilmer, Tona</creator><creator>Bottaro, Donald P</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20211223</creationdate><title>Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer</title><author>Shah, Manish A ; Wainberg, Zev A ; Catenacci, Daniel V T ; Hochster, Howard S ; Ford, James ; Kunz, Pamela ; Lee, Fa-Chyi ; Kallender, Howard ; Cecchi, Fabiola ; Rabe, Daniel C ; Keer, Harold ; Martin, Anne-Marie ; Liu, Yuan ; Gagnon, Robert ; Bonate, Peter ; Liu, Li ; Gilmer, Tona ; Bottaro, Donald P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4384-921d8a8e8e7bf065fb1fb861770f8211736a04eadb7ec7c6b0b8bf2c7838a8073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Metastasis</topic><topic>Stomach cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, Manish A</creatorcontrib><creatorcontrib>Wainberg, Zev A</creatorcontrib><creatorcontrib>Catenacci, Daniel V T</creatorcontrib><creatorcontrib>Hochster, Howard S</creatorcontrib><creatorcontrib>Ford, James</creatorcontrib><creatorcontrib>Kunz, Pamela</creatorcontrib><creatorcontrib>Lee, Fa-Chyi</creatorcontrib><creatorcontrib>Kallender, Howard</creatorcontrib><creatorcontrib>Cecchi, Fabiola</creatorcontrib><creatorcontrib>Rabe, Daniel C</creatorcontrib><creatorcontrib>Keer, Harold</creatorcontrib><creatorcontrib>Martin, Anne-Marie</creatorcontrib><creatorcontrib>Liu, Yuan</creatorcontrib><creatorcontrib>Gagnon, Robert</creatorcontrib><creatorcontrib>Bonate, Peter</creatorcontrib><creatorcontrib>Liu, Li</creatorcontrib><creatorcontrib>Gilmer, Tona</creatorcontrib><creatorcontrib>Bottaro, Donald P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, Manish A</au><au>Wainberg, Zev A</au><au>Catenacci, Daniel V T</au><au>Hochster, Howard S</au><au>Ford, James</au><au>Kunz, Pamela</au><au>Lee, Fa-Chyi</au><au>Kallender, Howard</au><au>Cecchi, Fabiola</au><au>Rabe, Daniel C</au><au>Keer, Harold</au><au>Martin, Anne-Marie</au><au>Liu, Yuan</au><au>Gagnon, Robert</au><au>Bonate, Peter</au><au>Liu, Li</au><au>Gilmer, Tona</au><au>Bottaro, Donald P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-12-23</date><risdate>2021</risdate><volume>16</volume><issue>12</issue><spage>e0261994</spage><epage>e0261994</epage><pages>e0261994-e0261994</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>[This corrects the article DOI: 10.1371/journal.pone.0054014.].</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34941969</pmid><doi>10.1371/journal.pone.0261994</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-12, Vol.16 (12), p.e0261994-e0261994
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2613264344
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Cancer patients
Care and treatment
Metastasis
Stomach cancer
title Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A33%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Phase%20II%20Study%20Evaluating%202%20Dosing%20Schedules%20of%20Oral%20Foretinib%20(GSK1363089),%20cMET/VEGFR2%20Inhibitor,%20in%20Patients%20with%20Metastatic%20Gastric%20Cancer&rft.jtitle=PloS%20one&rft.au=Shah,%20Manish%20A&rft.date=2021-12-23&rft.volume=16&rft.issue=12&rft.spage=e0261994&rft.epage=e0261994&rft.pages=e0261994-e0261994&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0261994&rft_dat=%3Cgale_plos_%3EA687760106%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2613264344&rft_id=info:pmid/34941969&rft_galeid=A687760106&rft_doaj_id=oai_doaj_org_article_3a8c73388258421cbed41f983d337c90&rfr_iscdi=true